Skip to content

Laryngeal Mask Supreme and I-Gel in Edentulate Geriatric Patients

Comparison of Laryngeal Mask Supreme and I-Gel in Edentulate Geriatric Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03760679
Enrollment
124
Registered
2018-11-30
Start date
2018-08-01
Completion date
2024-12-01
Last updated
2022-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Airway Morbidity

Keywords

laryngeal mask, geriatric, patient

Brief summary

The primary aim of this study is to evaluate ease and duration of placing Laryngeal Mask Supreme (LM) and applying I-gel in geriatric patients without teeth. The secondary aim is to compare their effects on ventilation parameters.

Detailed description

Prospective, randomized and double-blind study, aged from 18 to 65 years undergoing elective laparoscopic gynecological surgery. The patients are randomly assigned to 2 groups: * Group 1: i-gel * Group 2: laryngeal mask airway - Supreme Procedure: The investigation protocol contains the following sections: 1. Induction of anaesthesia: Preoxygenation will be provided at 6 Liter/min oxygen for three minutes by using a facial mask. After anesthesia induction with fentanyl 1-2 μg/kg and propofol 1-2 mg/kg (12), mask ventilation will be applied with 100% oxygen. 2. Bispectral index values will be held between 40-60.Bispectral index values will be within this interval by increasing or decreasing propofol infusion by 1 mg/kg after additional bolus dose of propofol (1 mg/kg). 3. Insertion of the airway device. The size of the airway device used is based on the manufacturers' recommendations. All devices are deflated a lubricated prior to use. Once inserted, the cuff is be inflated with a manometer up to 60 cm H20 Data recorded: size of airway device, time an number of attempts. 4. Maintenance of anesthesia will be achieved with sevoflurane 1,5-2,5% in a mixture of 50% O2/ 50% nitrogen protoxide. Sevoflurane concentrations will be adjusted to keep bispectral index values at 40-60. 5. Measurement of airway seal pressure (oropharyngeal leak pressure (OLP): at baseline, and two minutes after the airway tool is placed, every 15 minutes until the operation ends and before the airway tool is removed. 6. Ventilatory mechanics and parameters and hemodynamic parameters are measured at baseline, and two minutes after the airway tool is placed, every 15 minutes until the operation ends and before the airway tool is removed. 7. Perioperative complications: Cough, vomiting, laryngeal spasm, laryngeal Stridor 8. Removal of the airway device: Presence of blood - 3 level grading (1:no blood; 2: trace amounts of blood; 3: clear amounts of blood). Complications: sore throat (visual analogue scale :10-point scale), dysphonia (yes/no), dysphagia (yes/no).

Interventions

Device: Laryngeal mask Supreme evaluation

Device: i-gel evaluation

Sponsors

Dokuz Eylul University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* American Society of Anesthesiologists Classification I-III patients * patients aged 65 years and older

Exclusion criteria

* having teeth or fixed prosthesis * having a pathology of the neck or the upper respiratory tract * having a risk of regurgitation of gastric content/ aspiration (prior upper gastrointestinal system surgery, hiatus hernia, gastrointestinal reflux, history of peptic ulcer and full stomach) * history or possibility of difficult airway (history of impossible intubation, mallampati score of 3-4, sternomental distance of shorter than 12 cm, thyromental distance of shorter than 6cm, head extension of lower than 90 degrees and mouth opening of lower than 1.5 cm) * lower pulmonary compliance or higher airway resistance (morbid obesity -BMI\>35kg/m2- and pulmonary disease) Each patient will be examined preoperatively and American Society of Anesthesiologists Classification scores and mallampati scores will be recorded. Standard monitoring (ECG, pulse oximetry and noninvasive blood pressure measurement) and bispectral index monitoring will be performed in each patient before induction of anesthesia in the surgical room.

Design outcomes

Primary

MeasureTime frameDescription
Change in Airway Seal Pressure Valuesintraoperative
insertion timeintraoperativeplacement of airway device (second)

Secondary

MeasureTime frameDescription
sore throatpostoperative 1th hour and 24th hourpostoperative pharyngolaryngeal morbidity- (Visual Analog Pain Scale is a unidimensional measure of pain intensity ), (no pain (score of 0) and pain as bad as it could be or worst imaginable pain (score of 100 \[100-mm scale\])
dysphagiapostoperative 1th hour and 24th hourpostoperative pharyngolaryngeal morbidity- dysphagia (yes/no)
dysphoniapostoperative 1th hour and 24th hourpostoperative pharyngolaryngeal morbidity- dysphonia (yes/no)

Countries

Turkey (Türkiye)

Contacts

Primary ContactŞule Özbilgin
ozbilginsule@gmail.com05055252901
Backup ContactSibel Büyükçoban
sibelbuyukcoban@yahoo.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026